Clinical trial
A Phase II Study of Alemtuzumab in Autoimmune Cytopenias
NCT00472433 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Alemtuzumab in Autoimmune Cytopenias
- Lead sponsor
- Phramongkutklao College of Medicine and Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2007
- Completion date
- May 31, 2009
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune cytopenias